ANGO AngioDynamics, Inc. - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Sep 29, 2026
$15,11
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$9,3952-Wochen-Tief
$16,2952-Wochen-Hoch
Marktkapitalisierung (MRQ)
$630M
P/E (TTM)
-17.2
EPS (TTM)
$-0.88
Umsatz (TTM)
$320M
Ihre Abzeichen
52W-Spanne
$9–$16
Analystenbewertung
BUY
Kursziel
$20
P/E
-17.2
ROE
-20.8%
Nettogewinnmarge
-11.5%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ANGO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$15.11
Marktkapitalisierung (MRQ)
$630M
P/E (TTM)
-17.2
EPS (TTM)
$-0.88
Umsatz (TTM)
$320M
ROE (TTM)
-20.8%
52W-Spanne
$9–$16
ANGO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$320M2017-05-31 → 2026-05-31
EPS$-0.882017-05-31 → 2026-05-31
Freier Cashflow·2017-05-31 → 2025-05-31
Nettogewinnmarge-11.5%2017-05-31 → 2025-05-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ANGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -17.25-Jahres-Durchschnitt ≈-12.5 | ≈-12.5 | · | · | |
| P/S (TTM) | 2.05-Jahres-Durchschnitt ≈1.5 | ≈1.5 | 4.2 | Unterbewertet | |
| K/B (MRQ) | 3.75-Jahres-Durchschnitt ≈1.6 | ≈1.6 | 3.6 | Unterbewertet | |
| Kurs / FCF (TTM) | 1240.35-Jahres-Durchschnitt ≈-51.1 | ≈-51.1 | · | · | |
| Kurs / Cashflow (TTM) | 204.05-Jahres-Durchschnitt ≈1161.7 | ≈1161.7 | 18.9 | Überbewertet | |
| Kurs / Materieller Buchwert (MRQ) | 6.15-Jahres-Durchschnitt ≈4.9 | ≈4.9 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ANGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 54.6%5-Jahres-Durchschnitt ≈52.2% | ≈52.2% | 59.1% | Schwach | |
| Betriebsgewinnmarge (TTM) | -12.5%5-Jahres-Durchschnitt ≈-25.3% | ≈-25.3% | -10.5% | Unterdurchschnittlich | |
| Vorgewinnmarge (TTM) | -11.3%5-Jahres-Durchschnitt ≈-25.1% | ≈-25.1% | -12.9% | Im Einklang | |
| Nettogewinnmarge (TTM) | -11.5%5-Jahres-Durchschnitt ≈-24.0% | ≈-24.0% | -13.1% | Im Einklang | |
| ROA (TTM) | -13.4%5-Jahres-Durchschnitt ≈-17.3% | ≈-17.3% | -16.0% | Spitzenklasse | |
| ROE (TTM) | -20.8%5-Jahres-Durchschnitt ≈-31.3% | ≈-31.3% | -25.7% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ANGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 2.25-Jahres-Durchschnitt ≈2.1 | ≈2.1 | 5.1 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | ANGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 9.5%5-Jahres-Durchschnitt ≈2.2% | ≈2.2% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -1.9%5-Jahres-Durchschnitt ≈1.4% | ≈1.4% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 1.9% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | ANGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$506.6K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
76.0%
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | $-0.07 | $-0.09 | 23.7% | |
| 31. März 2026 | $0.02 | $-0.11 | 117.8% | |
| 31. Dezember 2025 | $0.00 | $-0.10 | 100.0% | |
| 30. September 2025 | $-0.10 | $-0.12 | 16.6% | |
| 30. Juni 2025 | $-0.03 | $-0.12 | 75.5% | |
| 31. März 2025 | $0.03 | $-0.13 | 122.6% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $320M | $292M | $304M | $339M | $316M | $291M | $264M | $271M | $262M | $270M | $354M | $357M | |
| Cost of Revenue | $145M | $135M | $149M | $165M | $150M | $134M | $114M | $115M | $118M | $126M | $180M | $181M | |
| Gross Profit | $175M | $158M | $155M | $174M | $166M | $157M | $150M | $156M | $144M | $144M | $174M | $176M | |
| R&D Expense | $29M | $26M | $32M | $30M | $31M | $36M | $30M | $28M | $24M | $24M | $25M | $27M | |
| SG&A Expense | $44M | $42M | $41M | $40M | $38M | $36M | $38M | $35M | $31M | $31M | $31M | $30M | |
| Operating Expenses | $215M | $198M | $402M | $225M | $194M | $192M | $317M | $165M | $158M | $155M | $173M | $179M | |
| Operating Income | $-40M | $-40M | $-192M | $-51M | $-28M | $-35M | $-167M | $-9M | $-14M | $-11M | $1M | $-3M | |
| Interest Expense | · | · | $-2M | $3M | $688.0K | $861.0K | $907.0K | $5M | $3M | $3M | $3M | $3M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | $11.0K | $4.0K | |
| Other Non-op | $4M | $5M | $-817.0K | $-554.0K | $-790.0K | $92.0K | $-130.0K | $-207.0K | $-3M | $-3M | $-4M | $-5M | |
| Pretax Income | $-36M | $-34M | $-192M | $-54M | $-30M | $-36M | $-168M | $-15M | $-17M | $-14M | $-3M | $-8M | |
| Income Tax | $442.0K | $-39.0K | $-7M | $-2M | $-3M | $-5M | $-1M | $-4M | $-11M | $-7M | $40M | $-5M | |
| Net Income | $-37M | $-34M | $-184M | $-52M | $-27M | $-32M | $-167M | $61M | $16M | $5M | $-44M | $-3M | |
| EPS (Basic) | $-0.88 | $-0.83 | $-4.59 | $-1.33 | $-0.68 | $-0.82 | $-4.39 | $1.64 | $0.44 | $0.14 | $-1.21 | $-0.09 | |
| EPS (Diluted) | $-0.88 | $-0.83 | $-4.59 | $-1.33 | $-0.68 | $-0.82 | $-4.39 | $1.64 | $0.44 | $0.14 | $-1.21 | $-0.09 | |
| Shares (Basic) | 41,526,000 | 40,853,000 | 40,181,000 | 39,480,000 | 39,009,000 | 38,342,000 | 37,961,000 | 37,485,000 | 37,075,000 | 36,617,000 | 36,161,000 | 35,683,139 | |
| Shares (Diluted) | 41,526,000 | 40,853,000 | 40,181,000 | 39,480,000 | 39,009,000 | 38,342,000 | 37,961,000 | 37,485,000 | 37,075,000 | 36,617,000 | 36,161,000 | 35,683,139 | |
| EBITDA | · | $-40M | $-192M | $-51M | $-28M | $-35M | $-167M | $-9M | $11M | $13M | · | $-994.0K |
Bilanz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $56M | $76M | $45M | $29M | $48M | $54M | $228M | $74M | $48M | $32M | $18M | |
| Receivables | $48M | $43M | $44M | $53M | $52M | $35M | $31M | $44M | $39M | $45M | $53M | $58M | |
| Inventory | $52M | $62M | $61M | $55M | $51M | $49M | $60M | $40M | $39M | $55M | $55M | $67M | |
| Prepaid Expense | $9M | $8M | $13M | $5M | $11M | $9M | $7M | $4M | $4M | $6M | $3M | $4M | |
| Current Assets | $163M | $168M | $193M | $164M | $143M | $141M | $153M | $315M | $168M | $154M | $146M | $151M | |
| PP&E (Net) | $27M | $32M | $36M | $44M | $45M | $37M | $28M | $24M | $26M | $45M | $48M | $54M | |
| PP&E (Gross) | · | · | $108M | $103M | $96M | $82M | $69M | $65M | $64M | $93M | $90M | $89M | |
| Accum. Depreciation | · | · | $70M | $59M | $51M | $46M | $41M | $42M | $39M | $50M | $44M | $36M | |
| Goodwill | · | · | $0 | $159M | $201M | $201M | $201M | $348M | $286M | $361M | $361M | $361M | |
| Intangibles | $67M | $69M | $77M | $111M | $152M | $169M | $197M | $145M | $113M | $146M | $167M | $182M | |
| Other Non-current Assets | $9M | $10M | $11M | $11M | $11M | $13M | $15M | $4M | $3M | $2M | $4M | $5M | |
| Total Assets | $267M | $280M | $318M | $533M | $553M | $561M | $594M | $836M | $705M | $708M | $726M | $773M | |
| Accounts Payable | $32M | $33M | $38M | $40M | $28M | $20M | $19M | $23M | $16M | $18M | $16M | $23M | |
| Accrued Liabilities | $39M | $36M | $41M | $27M | $35M | $35M | $29M | $38M | $34M | $39M | $22M | $18M | |
| Current Liabilities | $75M | $76M | $91M | $84M | $74M | $58M | $51M | $73M | $57M | $72M | $67M | $61M | |
| Capital Leases | $4M | $2M | $4M | $3M | $5M | $7M | $8M | · | · | · | · | · | |
| Other Non-current Liabilities | $16M | $17M | $16M | $3M | $5M | $9M | $9M | $521.0K | $621.0K | $850.0K | $908.0K | $0 | |
| Total Liabilities | $96M | $97M | $112M | $154M | $128M | $122M | $139M | $222M | $163M | $193M | $219M | $228M | |
| Long-term Debt | · | · | $0 | $50M | $25M | · | · | $132M | $92M | $96M | · | · | |
| Total Debt | · | · | · | · | · | · | $0 | $132M | $92M | $96M | · | $9M | |
| Common Stock | $387.0K | $385.0K | $385.0K | $382.0K | $380.0K | $377.0K | $374.0K | $372.0K | $370.0K | $367.0K | $363.0K | $360.0K | |
| Retained Earnings | $-466M | $-429M | $-395M | $-211M | $-158M | $-132M | $-100M | $66M | $5M | $-11M | $-16M | $28M | |
| Treasury Stock | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $2M | $2M | |
| AOCI | $8M | $-2M | $-4M | $-5M | $1M | $3M | $-1M | $-1M | $-952.0K | $-1M | $-791.0K | $-833.0K | |
| Stockholders' Equity | $171M | $183M | $206M | $378M | $424M | $439M | $455M | $615M | $543M | $515M | $507M | $545M | |
| Liabilities + Equity | $267M | $280M | $318M | $533M | $553M | $561M | $594M | $836M | $705M | $708M | $726M | $773M | |
| Shares Outstanding | 41,700,419 | 40,994,030 | 40,801,597 | 39,981,422 | 39,541,173 | 38,920,951 | 38,448,536 | 37,984,382 | 37,224,493 | 36,840,091 | 36,278,098 | 35,901,420 |
Cashflow
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $23M | $26M | $28M | $31M | $29M | $26M | $24M | $26M | $23M | $25M | $28M | $30M | |
| Stock-based Comp | $14M | $10M | $11M | $11M | $11M | $9M | $8M | $9M | $8M | $6M | $3M | $6M | |
| Deferred Tax | $143.0K | $-988.0K | $-8M | $-2M | $-4M | $-5M | $-2M | $-4M | $-11M | $-8M | $40M | $-5M | |
| Amort. of Intangibles | $11M | $10M | $13M | $19M | $19M | $18M | $18M | $17M | $14M | $15M | $18M | $18M | |
| Restructuring | $13M | $14M | · | · | · | · | $26.0K | $288.0K | $5M | $1M | $0 | · | |
| Operating Cash Flow | $3M | $-10M | $-28M | $78.0K | $-7M | $24M | $-15M | $37M | $41M | $56M | $45M | $26M | |
| CapEx | $3M | $4M | $3M | $4M | $4M | $5M | $7M | $3M | $2M | $3M | $2M | $11M | |
| Investing Cash Flow | $-6M | $-10M | $124M | $-10M | $-19M | $-14M | $-63M | $83M | $-4M | $-3M | $-8M | $-13M | |
| Debt Issued | · | · | · | · | · | · | · | $0 | $0 | $116M | $0 | $15M | |
| Net Debt Issued | · | $0 | $-50M | $-45M | $0 | $-20M | $-132M | $-15M | $-5M | $-24M | · | $-5M | |
| Stock Repurchased | $0 | $2M | $0 | $0 | · | · | · | $0 | $0 | $14M | $0 | $0 | |
| Net Stock Activity | · | $-2M | · | · | · | · | · | $0 | $0 | $-14M | · | · | |
| Financing Cash Flow | $564.0K | $-255.0K | $-64M | $25M | $8M | $-17M | $-95M | $34M | $-12M | $-38M | $-24M | $-10M | |
| Net Change in Cash | $-2M | $-20M | $31M | $16M | $-19M | $-6M | $-173M | $154M | $27M | $15M | $14M | $2M | |
| Taxes Paid | $405.0K | $800.0K | $455.0K | $342.0K | $329.0K | $313.0K | $682.0K | $426.0K | $36.0K | $-102.0K | $332.0K | · | |
| Free Cash Flow | · | $-15M | $-31M | $-4M | $-11M | $19M | $-22M | $34M | $39M | $53M | · | $14M | |
| Levered FCF | · | · | $-29M | $-6M | $-12M | $18M | $-23M | $30M | $32M | $51M | · | $13M |
Rentabilität
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 53.9% | 50.9% | 51.4% | 52.4% | 53.9% | 56.9% | 57.6% | 51.4% | 50.4% | · | 49.5% | |
| Operating Margin | · | -13.7% | -63.3% | -15.1% | -9.0% | -12.1% | -63.3% | -3.5% | 3.1% | 3.7% | · | -0.28% | |
| Net Margin | · | -11.6% | -60.7% | -15.5% | -8.4% | -10.8% | -63.1% | 22.7% | 4.7% | 1.4% | · | -0.92% | |
| Pretax Margin | · | -11.6% | -63.1% | -16.1% | -9.5% | -12.4% | -63.6% | -5.4% | 2.2% | 2.8% | · | -2.2% | |
| EBITDA Margin | · | -13.7% | -63.3% | -15.1% | -9.0% | -12.1% | -63.3% | -3.5% | 3.1% | 3.7% | · | -0.28% | |
| ROA | · | -11.4% | -43.4% | -9.7% | -4.8% | -5.5% | -23.3% | 8.0% | 2.3% | 0.70% | · | -0.42% | |
| ROE | · | -18.4% | -86.9% | -13.5% | -6.2% | -7.0% | -31.3% | 10.5% | 3.1% | 0.98% | · | -0.60% | |
| ROIC | · | -21.8% | -90.0% | -13.0% | -5.9% | -7.0% | -36.4% | -0.95% | 3.6% | 1.1% | · | -0.07% |
Liquidität & Solvenz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.2 | 2.1 | 2.0 | 1.9 | 2.4 | 3.0 | 4.3 | 2.9 | 2.2 | · | 2.5 | |
| Quick Ratio | · | 1.3 | 1.3 | 1.2 | 1.1 | 1.5 | 1.7 | 3.7 | 2.0 | 1.3 | · | 1.3 | |
| Debt / Equity | · | · | · | · | · | · | 0.0 | 0.2 | 0.2 | 0.2 | · | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | · | · | 0.2 | 0.2 | 0.2 | · | · | |
| Interest Coverage | · | · | 119.2 | -18.9 | -41.4 | -41.0 | -184.2 | -1.8 | 3.4 | 4.6 | · | -0.3 |
Effizienz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 1.0 | 0.7 | 0.6 | 0.6 | 0.5 | 0.4 | 0.4 | 0.5 | 0.5 | · | 0.5 | |
| Inventory Turnover | · | 2.2 | 2.6 | 3.1 | 3.0 | 2.5 | 2.3 | 2.9 | 3.2 | 3.2 | · | 2.6 | |
| Receivables Turnover | · | 6.8 | 6.3 | 6.4 | 7.2 | 8.7 | 7.1 | 6.5 | 8.2 | 7.2 | · | 5.9 |
Pro Aktie
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $4.46 | $5.08 | $9.55 | $10.84 | $11.40 | $11.95 | $16.35 | $14.58 | $13.98 | · | $15.12 | |
| Revenue / Share | · | $7.16 | $7.56 | $8.58 | $8.11 | $7.59 | $6.96 | $7.22 | $9.17 | $9.46 | · | $10.00 | |
| Cash Flow / Share | · | $-0.25 | $-0.70 | $0.00 | $-0.18 | $0.63 | $-0.38 | $1.00 | $1.10 | $1.51 | · | $0.74 | |
| Cash / Share | · | $1.36 | $1.88 | $1.13 | $0.74 | $1.25 | $1.43 | $6.05 | $1.99 | $1.29 | · | $0.51 | |
| EPS (TTM) | $-0.88 | $-0.83 | $-4.59 | $-1.33 | $-0.68 | $-0.82 | $-4.39 | $1.64 | $0.44 | $0.14 | $-1.21 | $-0.09 |
Wachstumsraten
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.5% | -3.8% | -10.3% | 7.1% | 8.7% | 10.2% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.9% | -2.6% | 1.5% | 8.6% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 1.9% | 2.1% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $320M | $292M | $304M | $339M | $316M | $291M | $264M | $271M | $262M | $270M | $354M | $357M | |
| Net Income TTM | $-37M | $-34M | $-184M | $-52M | $-27M | $-32M | $-167M | $61M | $16M | $5M | $-44M | $-3M | |
| Market Cap | · | $418M | $255M | $375M | $769M | $891M | $389M | $707M | $783M | $556M | · | $579M | |
| Enterprise Value | · | · | · | · | · | · | $334M | $611M | $800M | $604M | · | $569M | |
| P/E | -13.0 | -12.3 | -1.4 | -7.1 | -28.9 | -28.2 | -2.3 | 11.5 | 47.8 | 107.7 | -9.9 | -178.3 | |
| P/S | · | 1.4 | 0.8 | 1.1 | 2.4 | 3.1 | 1.5 | 2.6 | 3.0 | 2.1 | · | 1.6 | |
| P/B | · | 2.3 | 1.2 | 1.0 | 1.8 | 2.0 | 0.9 | 1.1 | 1.4 | 1.1 | · | 1.1 | |
| P / Tangible Book | 4.6 | 3.7 | 2.0 | 3.5 | 10.8 | 12.9 | 6.8 | · | · | · | · | · | |
| P / Cash Flow | · | -41.3 | -9.1 | 4804.2 | -106.9 | 37.0 | -26.7 | 18.9 | 19.0 | 10.0 | · | 22.0 | |
| P / FCF | · | -28.7 | -8.3 | -100.4 | -66.9 | 47.1 | -17.8 | 20.6 | 20.1 | 10.5 | · | 40.4 | |
| EV / EBITDA | · | · | · | · | · | · | -2.0 | -65.0 | 75.8 | 46.6 | · | -572.3 | |
| EV / FCF | · | · | · | · | · | · | -15.3 | 17.8 | 20.6 | 11.5 | · | 39.8 | |
| EV / Revenue | · | · | · | · | · | · | 1.3 | 2.3 | 3.1 | 2.2 | · | 1.6 | |
| Earnings Yield | -7.7% | -8.1% | -72.7% | -14.1% | -3.5% | -3.5% | -43.0% | 8.7% | 2.1% | 0.93% | -10.1% | -0.56% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $87M | $78M | $79M | $76M | $80M | $72M | $73M | $67M | $71M | $75M | $79M | $79M | $91M | $81M | $85M | $82M | |
| Cost of Revenue | $40M | $37M | $35M | $34M | $38M | $33M | $33M | $31M | $32M | $39M | $39M | $39M | $45M | $40M | $40M | $39M | |
| Gross Profit | $47M | $41M | $45M | $42M | $42M | $39M | $40M | $37M | $39M | $36M | $40M | $40M | $46M | $41M | $45M | $42M | |
| R&D Expense | $8M | $7M | $8M | $6M | $7M | $7M | $6M | $6M | $7M | $8M | $9M | $8M | $8M | $7M | $7M | $8M | |
| SG&A Expense | $10M | $11M | $10M | $13M | $10M | $10M | $10M | $11M | $10M | $11M | $9M | $11M | $10M | $9M | $11M | $10M | |
| Operating Expenses | $57M | $54M | $51M | $53M | $48M | $49M | $51M | $50M | $53M | $242M | $53M | $53M | $67M | $49M | $53M | $56M | |
| Operating Income | $-10M | $-13M | $-6M | $-11M | $-6M | $-10M | $-11M | $-13M | $-14M | $-200M | $-13M | $35M | $-21M | $-9M | $-8M | $-13M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $-394.0K | $-534.0K | $-119.0K | · | $736.0K | $684.0K | $381.0K | |
| Other Non-op | $-735.0K | $5M | $-128.0K | $-178.0K | $-325.0K | $5M | $12.0K | $-173.0K | $-259.0K | $-238.0K | $-32.0K | $-288.0K | $-127.0K | $0 | $-252.0K | $-175.0K | |
| Pretax Income | $-11M | $-8M | $-6M | $-11M | $-6M | $-4M | $-11M | $-13M | $-14M | $-200M | $-13M | $35M | $-22M | $-10M | $-9M | $-14M | |
| Income Tax | $370.0K | $12.0K | $-5.0K | $65.0K | $-60.0K | $-2.0K | $-110.0K | $133.0K | $-692.0K | $-12M | $16M | $-11M | $-398.0K | $-179.0K | $-565.0K | $-853.0K | |
| Net Income | $-11M | $-8M | $-6M | $-11M | $-6M | $-4M | $-11M | $-13M | $-13M | $-188M | $-29M | $46M | $-21M | $-9M | $-8M | $-13M | |
| EPS (Basic) | $-0.28 | $-0.19 | $-0.15 | $-0.26 | $-0.15 | $-0.11 | $-0.26 | $-0.31 | $-0.35 | $-4.67 | $-0.72 | $1.15 | $-0.55 | $-0.24 | $-0.21 | $-0.33 | |
| EPS (Diluted) | $-0.28 | $-0.19 | $-0.15 | $-0.26 | $-0.15 | $-0.11 | $-0.26 | $-0.31 | $-0.35 | $-4.67 | $-0.72 | $1.15 | $-0.55 | $-0.24 | $-0.21 | $-0.33 | |
| Shares (Basic) | · | 41,596,000 | 41,542,000 | 41,174,000 | · | 40,853,000 | 40,922,000 | 40,653,000 | · | 40,234,000 | 40,219,000 | 39,842,000 | · | 39,509,000 | 39,490,000 | 39,302,000 | |
| Shares (Diluted) | · | 41,596,000 | 41,542,000 | 41,174,000 | · | 40,853,000 | 40,922,000 | 40,653,000 | · | 40,234,000 | 40,219,000 | 39,968,000 | · | 39,509,000 | 39,490,000 | 39,302,000 | |
| EBITDA | · | $-13M | $-6M | $-11M | · | $-10M | $-11M | $-13M | · | $-200M | $-13M | $35M | · | $-9M | $-8M | $-13M |
Bilanz
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $38M | $42M | $39M | $56M | $45M | $54M | $55M | $76M | $78M | $61M | $58M | · | $30M | $30M | $25M | |
| Receivables | $48M | $46M | $44M | $43M | $43M | $43M | $43M | $40M | $44M | $49M | $52M | $50M | · | $51M | $53M | $54M | |
| Inventory | $52M | $59M | $66M | $62M | $62M | $63M | $66M | $65M | $61M | $58M | $64M | $60M | · | $64M | $63M | $58M | |
| Prepaid Expense | $9M | $14M | $10M | $13M | $8M | $15M | $12M | $13M | $13M | $11M | $9M | $8M | · | $8M | $13M | $16M | |
| Current Assets | $163M | $156M | $161M | $157M | $168M | $172M | $175M | $173M | $193M | $197M | $185M | $175M | · | $153M | $159M | $151M | |
| PP&E (Net) | $27M | $29M | $31M | $31M | $32M | $33M | $33M | $34M | $36M | $37M | $43M | $43M | · | $46M | $46M | $46M | |
| Goodwill | · | · | · | · | · | · | · | · | · | $0 | $159M | $159M | · | $200M | $201M | $201M | |
| Intangibles | $67M | $65M | $67M | $68M | $69M | $71M | $73M | $76M | $77M | $82M | $104M | $107M | · | $134M | $142M | $148M | |
| Other Non-current Assets | $9M | $10M | $11M | $10M | $10M | $10M | $10M | $11M | $11M | $9M | $8M | $9M | · | $11M | $11M | $11M | |
| Total Assets | $267M | $261M | $270M | $266M | $280M | $285M | $292M | $294M | $318M | $325M | $500M | $494M | · | $543M | $558M | $558M | |
| Accounts Payable | $32M | $29M | $35M | $32M | $33M | $30M | $35M | $31M | $38M | $35M | $38M | $25M | · | $36M | $35M | $29M | |
| Accrued Liabilities | $39M | $32M | $30M | $28M | $36M | $37M | $40M | $34M | $41M | $31M | $29M | $26M | · | $22M | $27M | $26M | |
| Current Liabilities | $75M | $66M | $72M | $68M | $76M | $78M | $89M | $77M | $91M | $86M | $78M | $57M | · | $70M | $74M | $66M | |
| Capital Leases | $4M | $4M | $4M | $2M | $2M | $3M | $3M | $3M | $4M | $2M | $3M | $3M | · | $3M | $3M | $4M | |
| Other Non-current Liabilities | $16M | $17M | $17M | $14M | $17M | $17M | $12M | $16M | $16M | $14M | $3M | $3M | · | $3M | $4M | $4M | |
| Total Liabilities | $96M | $87M | $93M | $87M | $97M | $100M | $105M | $97M | $112M | $106M | $98M | $66M | · | $145M | $150M | $144M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $50M | $50M | $50M | |
| Common Stock | $387.0K | $387.0K | $386.0K | $386.0K | $385.0K | $385.0K | $384.0K | $386.0K | $385.0K | $385.0K | $383.0K | $383.0K | · | $382.0K | $381.0K | $381.0K | |
| Retained Earnings | $-466M | $-455M | $-446M | $-440M | $-429M | $-423M | $-419M | $-408M | $-395M | $-382M | $-194M | $-165M | · | $-189M | $-180M | $-171M | |
| Treasury Stock | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | · | $6M | $6M | $6M | |
| AOCI | $8M | $3M | $998.0K | $61.0K | $-2M | $-4M | $-4M | $-3M | $-4M | $-3M | $-5M | $-6M | · | $-4M | $-288.0K | $807.0K | |
| Stockholders' Equity | $171M | $173M | $176M | $179M | $183M | $186M | $187M | $197M | $206M | $219M | $401M | $428M | $378M | $398M | $408M | $414M | |
| Liabilities + Equity | $267M | $261M | $270M | $266M | $280M | $285M | $292M | $294M | $318M | $325M | $500M | $494M | · | $543M | $558M | $558M | |
| Shares Outstanding | 41,700,419 | 41,682,097 | 41,574,212 | 41,446,782 | 40,994,030 | 40,970,831 | 40,835,709 | 41,004,249 | 40,801,597 | 40,424,533 | 40,224,406 | 40,216,641 | 39,981,422 | 39,606,422 | 39,504,144 | 39,477,751 |
Cashflow
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $6M | $6M | $6M | $6M | $6M | $7M | $7M | $7M | $8M | $7M | $7M | $8M | $8M | $8M | $8M | |
| Stock-based Comp | $4M | $3M | $3M | $4M | $2M | $2M | $3M | $3M | $2M | $3M | $2M | $4M | $3M | $2M | $3M | $3M | |
| Deferred Tax | $150.0K | $57.0K | $-48.0K | $-16.0K | $-193.0K | $-207.0K | $-249.0K | $-339.0K | $-825.0K | $-12M | $16M | $-11M | $-559.0K | $-227.0K | $-618.0K | $-907.0K | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | |
| Restructuring | $3M | $5M | $2M | $2M | $2M | $3M | $5M | $4M | $9M | $5M | · | · | · | · | · | · | |
| Operating Cash Flow | $17M | $-3M | $5M | $-16M | $19M | $-13M | $2M | $-18M | $5M | $-13M | $5M | $-26M | $16M | $1M | $7M | $-25M | |
| CapEx | $413.0K | $1M | $422.0K | $731.0K | $777.0K | $2M | $797.0K | $1M | $566.0K | $607.0K | $554.0K | $791.0K | $1M | $666.0K | $1M | $809.0K | |
| Investing Cash Flow | $-1M | $-2M | $-2M | $-2M | $-3M | $-3M | $-2M | $-2M | $-2M | $29M | $-2M | $98M | $-2M | $-2M | $-2M | $-4M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $0 | $0 | $70M | |
| Net Debt Issued | · | · | · | · | · | · | · | $0 | · | · | · | $-50M | · | · | · | $25M | |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 | $0 | $1M | $552.0K | $0 | $0 | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | · | · | $0 | · | · | · | $-552.0K | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-108.0K | $621.0K | $-92.0K | $143.0K | $-6M | $7M | $-1M | $-509.0K | $-5M | $694.0K | $-352.0K | $-60M | $0 | $941.0K | $103.0K | $24M | |
| Net Change in Cash | $16M | $-4M | $3M | $-17M | $11M | $-9M | $-916.0K | $-21M | $-2M | $18M | $3M | $13M | $15M | $254.0K | $5M | $-4M | |
| Free Cash Flow | · | · | · | $-17M | · | · | · | $-19M | · | · | · | $-27M | · | · | · | $-26M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $-27M | · | · | · | $-26M |
Rentabilität
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 52.9% | 56.4% | 55.3% | · | 54.0% | 54.8% | 54.4% | · | 47.7% | 50.9% | 50.9% | · | 50.2% | 52.8% | 51.9% | |
| Operating Margin | · | -16.5% | -7.7% | -14.1% | · | -13.9% | -15.2% | -19.4% | · | -265.9% | -16.6% | 44.5% | · | -11.1% | -9.5% | -16.3% | |
| Net Margin | · | -10.3% | -8.0% | -14.4% | · | -6.1% | -14.7% | -19.0% | · | -249.7% | -36.7% | 58.3% | · | -11.8% | -9.9% | -16.0% | |
| Pretax Margin | · | -10.3% | -8.0% | -14.3% | · | -6.1% | -14.9% | -18.8% | · | -265.7% | -16.0% | 44.3% | · | -12.0% | -10.6% | -17.0% | |
| EBITDA Margin | · | -16.5% | -7.7% | -14.1% | · | -13.9% | -15.2% | -19.4% | · | -265.9% | -16.6% | 44.5% | · | -11.1% | -9.5% | -16.3% | |
| ROA | · | -3.0% | -2.3% | -3.9% | · | -1.4% | -2.7% | -3.2% | · | -43.3% | -5.5% | 8.7% | · | -1.8% | -1.5% | -2.3% | |
| ROE | · | -4.5% | -3.5% | -5.8% | · | -2.2% | -3.6% | -4.1% | · | -60.9% | -7.2% | 10.9% | · | -2.3% | -2.0% | -3.1% | |
| ROIC | · | -7.5% | -3.5% | -6.0% | · | -5.4% | -5.9% | -6.7% | · | -85.9% | -7.5% | 10.8% | · | -2.2% | -1.9% | -3.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.4 | 2.2 | 2.3 | · | 2.2 | 2.0 | 2.3 | · | 2.3 | 2.4 | 3.1 | · | 2.2 | 2.2 | 2.3 | |
| Quick Ratio | · | 1.3 | 1.2 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.5 | 1.4 | 1.9 | · | 1.2 | 1.1 | 1.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 507.4 | 24.6 | -294.4 | · | -12.1 | -11.9 | -34.9 |
Effizienz
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.1 | |
| Inventory Turnover | · | 0.6 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | |
| Receivables Turnover | · | 1.8 | 1.8 | 1.8 | · | 1.5 | 1.5 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.7 | 1.9 | 1.8 |
Pro Aktie
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $4.16 | $4.24 | $4.32 | · | $4.54 | $4.57 | $4.79 | · | $5.41 | $9.97 | $10.64 | · | $10.04 | $10.33 | $10.49 | |
| Revenue / Share | · | $1.89 | $1.91 | $1.84 | · | $1.76 | $1.78 | $1.66 | · | $1.87 | $1.97 | $1.97 | · | $2.04 | $2.16 | $2.07 | |
| Cash Flow / Share | · | · | · | $-0.39 | · | · | · | $-0.45 | · | · | · | $-0.65 | · | · | · | $-0.63 | |
| Cash / Share | · | $0.91 | $1.00 | $0.94 | · | $1.09 | $1.32 | $1.34 | · | $1.94 | $1.51 | $1.43 | · | $0.76 | $0.76 | $0.62 | |
| EPS (TTM) | · | $-0.75 | $-0.67 | $-0.78 | · | $-1.03 | $-5.59 | $-6.05 | · | $-4.79 | $-0.36 | $0.15 | · | $-0.94 | $-0.83 | $-0.83 |
Bewertung (TTM)
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $314M | $307M | $301M | · | $283M | $286M | $293M | · | $324M | $330M | $336M | · | $335M | $328M | $321M | |
| Net Income TTM | · | $-31M | $-28M | $-32M | · | $-41M | $-225M | $-243M | · | $-192M | $-14M | $6M | · | $-37M | $-33M | $-33M | |
| Market Cap | · | $477M | $516M | $425M | · | $381M | $283M | $306M | · | $222M | $263M | $323M | · | $490M | $512M | $874M | |
| P/E | · | -15.3 | -18.5 | -13.2 | · | -9.0 | -1.2 | -1.2 | · | -1.1 | -18.1 | 53.5 | · | -13.2 | -15.6 | -26.7 | |
| P/S | · | 1.5 | 1.7 | 1.4 | · | 1.3 | 1.0 | 1.0 | · | 0.7 | 0.8 | 1.0 | · | 1.5 | 1.6 | 2.7 | |
| P/B | · | 2.8 | 2.9 | 2.4 | · | 2.0 | 1.5 | 1.6 | · | 1.0 | 0.7 | 0.8 | · | 1.2 | 1.3 | 2.1 | |
| P / Tangible Book | · | 4.4 | 4.7 | 3.8 | · | 3.3 | 2.5 | 2.5 | · | 1.6 | 1.9 | 2.0 | · | 7.7 | 7.8 | 13.4 | |
| P / Cash Flow | · | · | · | -26.7 | · | · | · | -16.8 | · | · | · | -12.5 | · | · | · | -35.3 | |
| Earnings Yield | · | -6.6% | -5.4% | -7.6% | · | -11.1% | -80.7% | -81.1% | · | -87.2% | -5.5% | 1.9% | · | -7.6% | -6.4% | -3.8% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|---|
| Umsatz | $320M | $292M | $304M | $339M | $316M |
| Bruttogewinnmarge % | · | 53.9% | 50.9% | 51.4% | 52.4% |
| Betriebsgewinnmarge % | · | -13.7% | -63.3% | -15.1% | -9.0% |
| Nettoergebnis | $-37M | $-34M | $-184M | $-52M | $-27M |
| Verwässerte EPS | $-0.88 | $-0.83 | $-4.59 | $-1.33 | $-0.68 |
| Kennzahl | 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | · | 2.2 | 2.1 | 2.0 | 1.9 |
| Quick Ratio | · | 1.3 | 1.3 | 1.2 | 1.1 |
| Kennzahl | 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|---|
| Freier Cashflow | · | $-15M | $-31M | $-4M | $-11M |
Institutionelle Eigentümer (13F) 172 Einreicher · $543.8M gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
172
Gehaltener Wert
$543.8M
Neue Positionen
32
Geschlossene Positionen
15
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 32 (+11 vs. Vorquartal) | 15 (-17 vs. Vorquartal) | 54 (-2 vs. Vorquartal) | 53 (-2 vs. Vorquartal) | -445K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $49.480.048 | 3.803.232 | 9,10% | Aktien |
| Point72 Asset Management, L.P. | $39.843.346 | 3.062.517 | 7,33% | Aktien |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $34.349.199 | 2.640.214 | 6,32% | Aktien |
| VANGUARD GROUP INC | $31.288.936 | 2.436.833 | 5,75% | Aktien |
| ARMISTICE CAPITAL, LLC | $28.595.980 | 2.198.000 | 5,26% | Aktien |
| ROYCE & ASSOCIATES LP | $25.627.553 | 1.969.835 | 4,71% | Aktien |
| Broadfin Holdings LLC | $23.659.114 | 1.818.533 | 4,35% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $22.048.255 | 1.694.716 | 4,05% | Aktien |
| KOTLER KEVIN | $21.997.218 | 1.713.789 | 4,04% | Aktien |
| WEBER CAPITAL MANAGEMENT LLC /ADV | $17.649.392 | 1.356.602 | 3,25% | Aktien |
| Nuveen, LLC | $15.603.649 | 1.199.358 | 2,87% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $13.282.661 | 1.020.658 | 2,44% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $12.613.870 | 969.497 | 2,32% | Aktien |
| STATE STREET CORP | $12.465.753 | 958.167 | 2,29% | Aktien |
| SEGALL BRYANT & HAMILL, LLC | $12.056.510 | 926.711 | 2,22% | Aktien |
| Bastion Asset Management Inc. | $10.782.584 | 923.270 | 1,98% | Aktien |
| Pier Capital, LLC | $10.494.881 | 806.678 | 1,93% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $10.188.456 | 783.125 | 1,87% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $9.547.818 | 733.883 | 1,76% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $9.009.867 | 692.534 | 1,66% | Aktien |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $8.732.312 | 671.200 | 1,61% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $7.664.932 | 589.157 | 1,41% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $5.735.380 | 440.844 | 1,05% | Aktien |
| MARSHALL WACE, LLP | $5.469.118 | 420.378 | 1,01% | Aktien |
| Western Standard LLC | $5.037.316 | 387.188 | 0,93% | Aktien |
| GOLDMAN SACHS GROUP INC | $4.981.750 | 382.917 | 0,92% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4.866.117 | 374.029 | 0,89% | Aktien |
| BANK OF AMERICA CORP /DE/ | $4.490.310 | 345.143 | 0,83% | Aktien |
| NORTHERN TRUST CORP | $4.289.749 | 329.727 | 0,79% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $3.984.443 | 306.260 | 0,73% | Aktien |
| Phocas Financial Corp. | $3.805.555 | 292.510 | 0,70% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $3.602.664 | 276.915 | 0,66% | Aktien |
| Manatuck Hill Partners, LLC | $3.597.265 | 276.500 | 0,66% | Aktien |
| First Eagle Investment Management, LLC | $3.596.419 | 276.435 | 0,66% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $3.363.983 | 258.569 | 0,62% | Aktien |
| MORGAN STANLEY | $3.360.665 | 258.314 | 0,62% | Aktien |
| TWO SIGMA ADVISERS, LP | $2.953.213 | 230.001 | 0,54% | Aktien |
| JPMORGAN CHASE & CO | $2.914.230 | 220.775 | 0,54% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2.852.104 | 219.224 | 0,52% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $2.509.967 | 192.926 | 0,46% | Aktien |
| Orion Porfolio Solutions, LLC | $2.417.826 | 185.844 | 0,44% | Aktien |
| MOORE CAPITAL MANAGEMENT, LP | $2.382.118 | 183.099 | 0,44% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $2.008.471 | 154.379 | 0,37% | Aktien |
| WHITE PINE CAPITAL LLC | $1.879.477 | 144.464 | 0,35% | Aktien |
| Bank of New York Mellon Corp | $1.619.089 | 124.450 | 0,30% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $1.577.762 | 121.273 | 0,29% | Aktien |
| SEI INVESTMENTS CO | $1.525.673 | 117.269 | 0,28% | Aktien |
| FMR LLC | $1.359.754 | 104.516 | 0,25% | Aktien |
| GLOBEFLEX CAPITAL L P | $1.355.057 | 104.155 | 0,25% | Aktien |
| Orion Portfolio Solutions, LLC | $1.324.272 | 141.030 | 0,24% | Aktien |
Aktivisten & 5%+-Eigentümer 7 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Avista Capital Partners GP, LLC (2), Avista Capital Partners, L.P. (2), Avista Capital Partners (Offshore), L.P. (2), Navilyst Medical Co-Invest, LLC (2) ×5 Einreichungen | 28. April 2017 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 23. Dezember 2008 | · | Erste Einreichung | · | SEC |
| Estate of Howard S. Stern., Linda B. Stern. ×4 Einreichungen | 28. Juni 2007 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 16. Mai 2005 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 14. Februar 2005 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 12. November 2004 | · | Erste Einreichung | Passive Anlage | SEC |
| Nicht offengelegter meldender Beteiligter | 21. Oktober 2004 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 58 Insider · 27 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| James C Clemmer | President and CEO | 22. Juli 2026 M | 862.448 | 1 | 0 | $111.500 |
| Joseph Devivo | President and CEO | 8. September 2015 F | 198.451 | 0 | 0 | $0 |
| Scott J. Solano | Interim CEO | 3. August 2011 A | 8.945 | 0 | 0 | $0 |
| Jan Keltjens | President & CEO | 19. Januar 2011 F | 109.276 | 0 | 0 | $0 |
| Stephen A Trowbridge | EVP and CFO | 22. Juli 2026 M | 305.796 | 1 | 0 | $9.932 |
| Michael Greiner | EVP and CFO | 16. Oktober 2019 A | 33.438 | 0 | 0 | $0 |
| Mark T Frost | EVP and CFO | 6. August 2015 F | 38.389 | 0 | 0 | $0 |
| Joseph D Gersuk | EVP - CFO | 4. September 2012 F | 47.275 | 0 | 0 | $0 |
| George W. Bourne IV | CTO and COO | 6. August 2014 F | 23.613 | 0 | 0 | $0 |
| Warren Nighan JR | SVP Quality and Regulatory | 30. Juli 2026 S | 64.745 | 0 | 1 | $-344.006 |
| Laura Piccinini | SVP International | 22. Juli 2026 M | 81.929 | 0 | 0 | $0 |
| Chad Thomas Campbell | SVP/GM, Vascular Access | 22. Juli 2026 M | 108.676 | 0 | 0 | $0 |
| Lawrence T Weiss | SVP, Chief Legal Officer | 15. Juli 2026 A | 112.618 | 1 | 0 | $118.100 |
| Scott Centea | SVP/GM, VIT | 19. Juli 2023 M | 62.951 | 0 | 0 | $0 |
| Dave Helsel | SVP Global Operations and R&D | 19. Juli 2023 M | 34.462 | 0 | 0 | $0 |
| Richard C Rosenzweig | SVP and General Counsel | 1. Februar 2023 F | 15.730 | 0 | 0 | $0 |
| Brent J. Boucher | SVP and GM of Oncology | 12. Februar 2020 F | 15.416 | 0 | 0 | $0 |
| Robert Arthur Simpson | SVP/GM, Global Vascular | 12. Juli 2019 M | 25.883 | 0 | 0 | $0 |
| Stark Richard | SVP, GM - Oncology | 15. November 2017 M | 20.754 | 0 | 0 | $0 |
| Charles R Greiner | VP - Global Franchise | 6. Mai 2016 S | 20.910 | 0 | 0 | $0 |
| John Soto | SVP and CCO | 10. September 2015 F | 22.452 | 0 | 0 | $0 |
| Matthew C Kapusta | SVP, Business Development | 17. November 2014 F | 30.062 | 0 | 0 | $0 |
| Stephen Mcgill | SVP, GM - International | 28. Januar 2014 F | 20.715 | 0 | 0 | $0 |
| Richard Scott Etlinger | SVP - Global Operations | 17. August 2012 A | 11.957 | 0 | 0 | $0 |
| Alan Panzer | SVP, GM - Vascular | 17. August 2012 A | 27.500 | 0 | 0 | $0 |
| Shawn P Mccarthy | SVP - General Manager | 17. August 2010 F | 10.392 | 0 | 0 | $0 |
| Lynda M. Wallace | SVP - Business Development | 17. Mai 2010 A | · | 0 | 0 | $0 |
| Lorinda Burgess | Direktor | 15. Juli 2026 A | 67.144 | 0 | 0 | $0 |
| Karen A Licitra | Direktor | 15. Juli 2026 A | 102.322 | 0 | 0 | $0 |
| Michael E Tarnoff | Direktor | 15. Juli 2026 A | 95.265 | 0 | 0 | $0 |
| Eileen O'Shea Auen | Direktor | 15. Juli 2026 A | 116.605 | 0 | 0 | $0 |
| Wesley Johnson | Direktor | 15. Juli 2026 A | 155.425 | 0 | 0 | $0 |
| Howard W Donnelly | Direktor | 15. Juli 2026 A | 178.938 | 0 | 0 | $0 |
| Jan Stern Reed | Direktor | 15. Juli 2026 A | 116.921 | 0 | 0 | $0 |
| Dennis S Meteny | Direktor | 19. Juli 2023 A | 140.019 | 0 | 0 | $0 |
| Kevin J Gould | Direktor | 14. Juli 2020 A | 77.504 | 0 | 0 | $0 |
| Jeffrey Gold | Direktor | 17. Juli 2019 A | 83.640 | 0 | 0 | $0 |
| Steve Laporte | Direktor | 18. Juli 2018 A | 48.484 | 0 | 0 | $0 |
| David F Burgstahler | Direktor | 12. April 2017 S | 381.406 | 0 | 0 | $0 |
| Vincent Bucci | Direktor | 23. Oktober 2013 A | 88.312 | 0 | 0 | $0 |
| Charles Thomas Orsatti | Direktor | 3. August 2011 A | 2.000 | 0 | 0 | $0 |
| Paul S Echenberg | · | 23. April 2012 M | 154.412 | 0 | 0 | $0 |
| Harold Mapes | · | 7. September 2010 M | 14.934 | 0 | 0 | $0 |
| William M Appling | · | 7. September 2010 M | 16.636 | 0 | 0 | $0 |
| Robert M Rossell | · | 8. Oktober 2009 A | 8.945 | 0 | 0 | $0 |
| Eamonn P Hobbs | · | 13. Februar 2009 S | 100.401 | 0 | 0 | $0 |
| Robert E Flaherty | · | 6. August 2008 A | 3.700 | 0 | 0 | $0 |
| Robert D Mitchell | · | 17. August 2007 A | 1.242 | 0 | 0 | $0 |
| Daniel Recinella | · | 17. August 2007 A | 1.196 | 0 | 0 | $0 |
| Brian Kunst | · | 17. August 2007 A | 1.500 | 0 | 0 | $0 |
| Joseph G Gerardi | · | 17. August 2007 A | 5.052 | 0 | 0 | $0 |
| Paul J Shea | · | 9. August 2007 M | 2.562 | 0 | 0 | $0 |
| Linda B Stern | · | 20. Dezember 2006 M | 0 | 0 | 0 | $0 |
| Peter J Graham | · | 25. Oktober 2006 M | 27.778 | 0 | 0 | $0 |
| Gregory D Casciaro | · | 15. August 2006 A | 500 | 0 | 0 | $0 |
| David P Meyers | · | 15. August 2006 A | 356.980 | 0 | 0 | $0 |
| Howard S Stern | · | 28. Dezember 2005 S | 1.647.687 | 0 | 0 | $0 |
| EZ EM INC | · | 11. Oktober 2004 J | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 27 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,49% | 7.431 SH | 2. Oktober 2026 | Täglich |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,37% | 100.041 SH | 2. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,13% | 126.421 SH | 11. September 2026 | Täglich |
| IHI · iShares Trust | 0,09% | 197.283 SH | 11. September 2026 | Täglich |
| VFMF · VANGUARD WELLINGTON FUND | 0,09% | 50.141 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 61.513 SH | 2. Oktober 2026 | Täglich |
| VFQY · VANGUARD WELLINGTON FUND | 0,03% | 9.180 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 24.898 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,02% | 955.368 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,02% | 17.796 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 137.468 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 484.612 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 214.186 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 9.350 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 108.819 SH | 19. August 2026 | Täglich |
| IWO · iShares Trust | 0,01% | 83.883 SH | 11. September 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,01% | 1.917 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 110.473 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 5.298 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 3.043 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 83.876 SH | 11. September 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,00% | 10.769 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 10.501 SH | 3. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 9.874 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.173.227 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.942 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 259.544 SH | 11. September 2026 | Täglich |
ANGO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 10 Analysten
KAUF
Median-Ziel
$19.50
+29,1%
2 20,0%
Starker Kauf
7 70,0%
Kauf
1 10,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
4 Analysten · 2026-10-01Mittelwert-Ziel $20.00 +32,4%
← Unter allen Zielen
Aktueller Preis $15.11
Tief$17.00
Mittelwert$20.00
Hoch$24.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ANGO | · | -13.0 | 9.5% | · | · | · |
| CBLL | $822M | -15.0 | 36.1% | -60.0% | -32.6% | 87.9% |
| SIBN | $861M | -44.8 | 20.2% | -9.4% | -10.9% | 79.6% |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| AVR | $207M | -2.0 | -29.2% | -4921.3% | -300.5% | · |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | · |
| SSII | · | -94.7 | 105.7% | · | · | · |
| DCTH | $350M | 144.3 | 129.1% | 3.2% | 2.5% | 86.2% |
| SENS | $228M | -3.3 | 56.9% | -196.0% | -88.7% | 44.7% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-K/A eingereicht Sep 29, 2026